Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations

Brittany A. Petros, Jacquelyn Turcinovic, Nicole L. Welch, Laura F. White, Eric D. Kolaczyk, Matthew R. Bauer, Michael Cleary, Sabrina T. Dobbins, Lynn Doucette-Stamm, Mitch Gore, Parvathy Nair, Tien G. Nguyen, Scott Rose, Bradford P. Taylor, Daniel Tsang, Erik Wendlandt, Michele Hope, Judy T. Platt, Karen R. Jacobson, Tara Bouton, Seyho Yune, Jared R. Auclair, Lena Landaverde, Catherine M. Klapperich, Davidson H. Hamer, William P. Hanage, Bronwyn L. MacInnis, Pardis C. Sabeti, John H. Connor, Michael Springer
doi: https://doi.org/10.1101/2022.01.27.22269787

Article Information

doi 
https://doi.org/10.1101/2022.01.27.22269787
History 
  • January 28, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Brittany A. Petros, A.B.*,1,2,3,4,
  2. Jacquelyn Turcinovic, B.S.*,5,6,
  3. Nicole L. Welch, B.S.2,7,
  4. Laura F. White, Ph.D.8,
  5. Eric D. Kolaczyk, Ph.D.9,10,
  6. Matthew R. Bauer, B.S.2,11,
  7. Michael Cleary, B.S.12,
  8. Sabrina T. Dobbins, M.S.2,
  9. Lynn Doucette-Stamm, Ph.D.13,
  10. Mitch Gore, Ph.D.14,
  11. Parvathy Nair, B.S.15,
  12. Tien G. Nguyen, B.S.2,
  13. Scott Rose, Ph.D.14,
  14. Bradford P. Taylor, Ph.D.16,
  15. Daniel Tsang, B.Sc.14,
  16. Erik Wendlandt, Ph.D.14,
  17. Michele Hope, M.H.A., B.S.12,
  18. Judy T. Platt, M.D.17,
  19. Karen R. Jacobson, M.D., M.P.H.18,
  20. Tara Bouton, M.D., M.P.H.18,
  21. Seyho Yune, M.D.19,
  22. Jared R. Auclair, Ph.D.20,21,22,
  23. Lena Landaverde, M.S.13,23,
  24. Catherine M. Klapperich, Ph.D.13,17,24,
  25. Davidson H. Hamer, M.D.5,18,24,25,26,
  26. William P. Hanage, Ph.D.16,
  27. Bronwyn L. MacInnis, Ph.D.2,
  28. Pardis C. Sabeti, M.D., D.Phil.+,2,15,27,28,29,30,
  29. John H. Connor, Ph.D.+,5,6,31 and
  30. Michael Springer, Ph.D.+&,1,2
  1. 1Department of Systems Biology, Harvard Medical School, Boston, MA, USA 02115
  2. 2Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA 02142
  3. 3Division of Health Sciences and Technology, Harvard Medical School and MIT, Cambridge, MA, USA 02139
  4. 4Harvard/MIT MD-PhD Program, Boston, MA, USA 02115
  5. 5National Emerging Infectious Diseases Laboratories, Boston, MA, USA 02118
  6. 6Bioinformatics Program, Boston University, Boston, MA, USA, 02215
  7. 7Harvard Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA, USA 02115
  8. 8Department of Biostatistics, School of Public Health, Boston University, Boston, MA, USA 02115
  9. 9Department of Mathematics & Statistics, Boston University, Boston, MA 02215
  10. 10Rafik B. Hariri Institute for Computing and Computational Science and Engineering, Boston University, Boston, MA, USA 02215
  11. 11Harvard Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard Medical School, Boston, MA, USA 02115
  12. 12Harvard University Clinical Laboratory, Harvard University, Cambridge, MA, USA 02138
  13. 13Boston University Clinical Testing Laboratory, Boston, MA, USA 02215
  14. 14Integrated DNA Technologies, Inc., Coralville, IA, USA 52241
  15. 15Howard Hughes Medical Institute, Chevy Chase, MD, USA 20815
  16. 16Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA 02115
  17. 17Boston University Student Health Services, Boston, MA, USA 02215
  18. 18Section of Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA 02215
  19. 19Student Affairs, Northeastern University, Boston, MA, USA 02115
  20. 20Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA, USA 02115
  21. 21Life Sciences Testing Center, Northeastern University, Burlington, MA, USA 01803
  22. 22Biopharmaceutical Analysis and Training Laboratory, Burlington, MA, USA 01803
  23. 23Department of Biomedical Engineering, Boston University, Boston, MA, USA 02215
  24. 24Boston University Precision DIagnostics Center, Boston University, Boston, MA, USA 02215
  25. 25Department of Global Health, Boston University School of Public Health, Boston, MA, USA 02215
  26. 26Center for Emerging Infectious Disease Research and Policy, Boston University, Boston, MA 02118
  27. 27Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, USA 02138
  28. 28Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA 02115
  29. 29Department of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA 02114
  30. 30Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA
  31. 31Department of Microbiology, Boston University School of Medicine, Boston, MA, USA 02218
  1. ↵&Author to whom correspondence should be addressed, michael_springer{at}hms.harvard.edu.

  1. ↵* These authors contributed equally to the work.

Back to top
Posted January 28, 2022.
Download PDF
Data/Code
Email
Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations
Brittany A. Petros, Jacquelyn Turcinovic, Nicole L. Welch, Laura F. White, Eric D. Kolaczyk, Matthew R. Bauer, Michael Cleary, Sabrina T. Dobbins, Lynn Doucette-Stamm, Mitch Gore, Parvathy Nair, Tien G. Nguyen, Scott Rose, Bradford P. Taylor, Daniel Tsang, Erik Wendlandt, Michele Hope, Judy T. Platt, Karen R. Jacobson, Tara Bouton, Seyho Yune, Jared R. Auclair, Lena Landaverde, Catherine M. Klapperich, Davidson H. Hamer, William P. Hanage, Bronwyn L. MacInnis, Pardis C. Sabeti, John H. Connor, Michael Springer
medRxiv 2022.01.27.22269787; doi: https://doi.org/10.1101/2022.01.27.22269787
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area